Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Trends in Molecular Medicine|September 18, 2022
Antibody class-switching as a strategy to improve HIV-1 neutralizationCathrine Scheepers, Simone I Richardson, Thandeka Moyo-Gwete, et al.
Vaccines|September 28, 2024
Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising AntibodiesKegomoditswe Malebo, Jeremy Woodward, Phindile Ximba, et al.
Structure (London, England : 1993)|February 5, 2026
Defining the mechanism of cross-reactivity for a SARS-CoV-2 Beta-elicited antibody toward omicron sub-lineagesFrances Ayres, Bronwen Lambson, Nonhlanhla N Mkhize, et al.
Plos Pathogens|September 2, 2022
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodiesCathrine Scheepers, Prudence Kgagudi, Nonkululeko Mzindle, et al.
Scientific Reports|June 10, 2024
Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey (Vervet) modelThandeka Moyo-Gwete, Frances Ayres, Nonkululeko B Mzindle, et al.
Scientific Reports|October 1, 2022
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanismsThandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
Communications Medicine|February 13, 2026
Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohortAfrah Khairallah, Zesuliwe Jule, Alice Piller, et al.
Viruses|October 26, 2021
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme-The South African ExperienceTanya Nadia Glatt, Caroline Hilton, Cynthia Nyoni, et al.
Frontiers in Immunology|August 21, 2023
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccinationBoitumelo M Motsoeneng, Nelia P Manamela, Haajira Kaldine, et al.
Vaccine|July 6, 2025
Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-CTimothy F Spracklen, Jonathan Day, Hamza Van Der Ross, et al.
Pageof 5